---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038279"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2023-10-25T23:59:59+00:00"
generated_at: "2026-06-09T11:49:03.248875+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# MIRA Pharmaceuticals appoints Brian Daly to Board, David Vorhoff resigns

## Summary
- Brian Daly appointed to Board of Directors on October 25, 2023.
- Daly named Audit Committee Chair and Compensation Committee member.
- David Vorhoff resigned from Board on October 19, 2023, with no disagreements.
- Daly brings over 30 years of Wall Street experience; currently Managing Partner at Dalglish Investment Holdings.

## SEC filing metadata
- accession: 0001493152-23-038279
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2023-10-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038279
- JSON: https://secwatch.observer/filing/0001493152-23-038279.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038279.txt

## Key facts
- Executive change
  David Vorhoff resigned as Director at MIRA PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: Also, on October 19, 2023, David Vorhoff, resigned from the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm
- Executive change
  Brian Daly was appointed as Director at MIRA PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Director
  source text: On October 25, 2023, the Board of Directors (the “Board”) of MIRA Pharmaceuticals, Inc. (the “Company”) unanimously approved the election and appointment of Mr. Brian Daly to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.